[1] Bousquet J,Vignola AM,Campbell AM,et al.Pathophysiology of allergic rhinitis [J].Int Arch Allergy Immunol,1996,110(3):207-218.
[2] Yousuf M,Al Suleimani,Michael JA.Walker.Allergic rhinitis and its pharmacology[J].Pharmacology & Therapeutics,2007,114(2):233-260.
[3] Tanaka K,Okamoto Y,Nagaya Y,et al.A nasal allergy model developed in the guinea pig by intranasal application of 2,4-toluene diisocyanate[J].Int Arch Allergy Appl Immunol,1988,85(4):392-397.
[4] 王伯沄,李玉松.病理学技术[M].北京:人民卫生出版社,2000:122-125.
[5] 刘云霞,黄家淼,宗晓福,等.COPD与哮喘体外过敏原血清特异性IgE检测的结果分析[J].东南国防医药,2007,9(2):84-85.
[6] 王素敏,章如新,于雁灵,等.变应性鼻炎豚鼠鼻黏膜组胺含量对血流量的影响[J].第二军医大学学报,2000,21(1):1130-1132.
[7] Ogawa M,Tsumuro T,Takubo M,et al.Effect of mometasone furoate on nasal congestion model in rats [J].Pharmacology,2009,84(4):99-103.
[8] Zhao Y,Woo JK,Leung PC,et al.Symptomatic and pathophysiological observations in a modified animal model of allergic rhinitis[J].Rhinology,2005,43(1):47-54.
[9] Fukuda S,Midoro K,Gyoten M,et al.Effects of TAK-427 on acute nasal symptoms and nasal obstruction in guinea pig model of experimental allergic rhinitis[J].Eur J Pharmacol,2003,476(3):239-247.
[10] Kemp AS.Allergic rhinitis[J].Paediatr Respirat Rev,2009,10(2):63-68.
[11] Takahashi Y,Kagana Y,Lzana K,et al.Effect of histamine H4 receptor antagonist on allergic rhinitis in mice[J].Intern Immunopharmacol,2009,9:734-738.
[12] Inoue N,Hashino A,Kageyama K,et al.Pharmacological profile of the novel anti-inflammatory corticosteroid Ns-126,a therapeutic agent for allergic rhinitis[J].J Pharmacol Sci,2010,112(1):73-82.
[1]钱旭东,周锦川,邵先安,等.IL-32在变应性鼻炎及慢性鼻-鼻窦炎鼻黏膜组织中的表达[J].医学研究与战创伤救治(原医学研究生学报),2018,20(02):189.[doi:10.3969/j.issn.1672-271X.2018.02.019]